The U.S. Food and Drug Administration (FDA) has issued warning letters to two Chinese firms concerning lab practices potentially impacting data produced by the lab.
This Week: Fed drops its benchmark cost-of-money rate from 5.25-5.50% to 4.75-5.25%, down 500 basis points. It's a clear signal the Fed is willing to do what it takes to support economic growth and ...